R
Richard H. Greiner
Researcher at University of Bern
Publications - 73
Citations - 5595
Richard H. Greiner is an academic researcher from University of Bern. The author has contributed to research in topics: Radiation therapy & Survival rate. The author has an hindex of 26, co-authored 73 publications receiving 5071 citations.
Papers
More filters
Journal ArticleDOI
Postoperative Irradiation With or Without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
Jacques Bernier,Christian Domenge,Mahmut Ozsahin,Katarzyna Matuszewska,Jean-Louis Lefebvre,Richard H. Greiner,Jordi Giralt,Philippe Maingon,Frederic Rolland,M. Bolla,Francesco Cognetti,Jean Bourhis,Anne Kirkpatrick,Martine Van Glabbeke +13 more
TL;DR: Postoperative concurrent administration of high-dose cisplatin with radiotherapy is more efficacious than radiotherapy alone in patients with locally advanced head and neck cancer and does not cause an undue number of late complications.
Journal Article
Expression of hypoxia-inducible factor-1α : A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer
Daniel M. Aebersold,Philipp Burri,Karl T. Beer,Jean A. Laissue,Valentin Djonov,Richard H. Greiner,Gregg L. Semenza +6 more
TL;DR: It is concluded that HIF-1alpha is overexpressed in the vast majority of patients with squamous cell cancer of the oropharynx and that the degree of expression has predictive and prognostic significance in individuals undergoing curative radiation therapy.
Journal ArticleDOI
The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants.
Sylvie Berthou,Daniel M. Aebersold,Laura S. Schmidt,Deborah Stroka,Christine Heigl,Bruno Streit,Denise Stalder,Guenther Gruber,Congxin Liang,Anthony R. Howlett,Daniel Candinas,Richard H. Greiner,Kenneth E. Lipson,Yitzhak Zimmer +13 more
TL;DR: It is reported that the Met kinase inhibitor SU11274 differentially affects the kinase activity and subsequent signaling of various mutant forms of Met, and the basis for the sensitivity or resistance to SU 11274 is discussed in terms of the position of the mutations predicted from a homology model.
Journal ArticleDOI
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
Jacques Bernier,Christian Domenge,Mahmut Ozsahin,K. Matuszewska,Jean-Louis Lefebvre,Richard H. Greiner,Jordi Giralt,Philippe Maingon,Frederic Rolland,M. Bolla,Francesco Cognetti,J. H. Bourhis,Anne Kirkpatrick,M. van Glabbeke,Bouchra Amaoui,J. J. Mazeron +15 more
Journal ArticleDOI
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.
Markus Borner,M. Bacchi,A. Goldhirsch,Richard H. Greiner,F Harder,Monica Castiglione,W F Jungi,Beat Thürlimann,Franco Cavalli,J P Obrecht +9 more
TL;DR: Systemic therapy with TAM after isolated locoregional recurrence of breast cancer significantly increased 5-year DFS rates from 36% to 59% compared with observation alone and prolonged median DFS by more than 4.5 years.